Andreas Segerros
Voorzitter bij DEXTECH MEDICAL AB
Oorsprong van het eerstegraads netwerk van Andreas Segerros
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors.
8
| Private Company | Investment Managers | 8 |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
| Public Company | Pharmaceuticals: Major | 6 | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden.
5
| Holding Company | Pharmaceuticals: Major | 5 |
3
| Public Company | Pharmaceuticals: Major | 3 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain.
2
| Subsidiary | Biotechnology | 2 |
Eir Ventures Danmark ApS
1
| Subsidiary | Investment Managers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andreas Segerros via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Heartcore Capital A/S | Investment Managers | Founder Private Equity Investor Director/Board Member Private Equity Investor | |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Head-Equity Investments Private Equity Investor Chief Investment Officer | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of Lund | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Ascelia Incentive AB | Chairman Director/Board Member | ||
| HQ AB | Investment Banks/Brokers | Director of Finance/CFO President | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
Zelnova Zeltia SA
 Zelnova Zeltia SA Chemicals: AgriculturalProcess Industries Zelnova Zeltia SA engages in the production and marketing of chemical products for their domestic, agricultural and industrial use. The firm specializes in insecticides, pesticides, air fresheners, cleaners, disinfectants, and fertilizers. It also offers the supply, contracting, and provision of disinfection, pest control, and deratization services in hospitals and clinics. The company was founded on December 30, 1991 and is headquartered in O Porrino, Spain. | Chemicals: Agricultural | Director/Board Member Chairman | |
| University of Santiago de Compostela | College/University | Corporate Officer/Principal Undergraduate Degree | |
Bygg Vesta AB
 Bygg Vesta AB Real Estate DevelopmentFinance Bygg Vesta AB develops and manages properties. The private company is based in Nacka, Sweden and has subsidiaries in Sweden. | Real Estate Development | Director/Board Member Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Founder | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Founder | |
Cooper Zeltia SA
 Cooper Zeltia SA Medical/Nursing ServicesHealth Services Cooper Zeltia SA is a private company based in Madrid, Spain. | Medical/Nursing Services | Director/Board Member Chairman | |
| PHARMA MAR, S.A. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
| ICI Zeltia SA | Director/Board Member Director/Board Member | ||
| ASCELIA PHARMA AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Neo4j, Inc.
 Neo4j, Inc. Packaged SoftwareTechnology Services Neo4j, Inc. develops and provides databases management system. Its solutions include fraud detection, graph based search, identity and access, master data management, network and it operations, recommendation engine, social network and retail. The company was founded by Emil Eifrem, Johan Svensson and Peter Neubauer in 2000 and is headquartered in San Mateo, CA. | Packaged Software | Director/Board Member Director/Board Member | |
DSM Pharmaceutical Products, Inc.
 DSM Pharmaceutical Products, Inc. Chemicals: Major DiversifiedProcess Industries Part of Thermo Fisher Scientific, Inc., DSM Pharmaceutical Products, Inc. is a science-based company that specializes in nutrition, health, and bioscience. The company is based in Parsippany, NJ. The company offers solutions for animal nutrition, human nutrition and care, food and beverage, and materials. DSM's companies cover a range of human and animal health and nutrition businesses. DSM's investor relations team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Seriously Digital Entertainment Oy
 Seriously Digital Entertainment Oy Packaged SoftwareTechnology Services Seriously Digital Entertainment Oy designs and develops mobile games. The company was founded by Reko Ukko, Tommi Kiviniemi, Andrew Stalbow, and Petri Järvilehto in August 2013 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member | |
Ascio Technologies A/S
 Ascio Technologies A/S Internet Software/ServicesTechnology Services Ascio Technologies A/S offers domain portfolio management services. It serves telecom operators, webhosting companies, internet access providers, and IP law firms. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. | Internet Software/Services | Founder | |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Veryan Medical Ltd.
 Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of London | College/University | Graduate Degree | |
Metacore Games Oy
 Metacore Games Oy Packaged SoftwareTechnology Services Metacore Games Oy provides video game development based on wearable smartwatch devices. Its studio is the first significant player to enter the wearable games market, aiming to create fresh gaming experiences optimized for smartwatches and tailored to fit naturally with everyday life. The company was founded by Markus Tuppurainen, Aki Järvilehto and Mika Tammenkoski in December 2014 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member | |
Freespee AB
 Freespee AB Miscellaneous Commercial ServicesCommercial Services Freespee AB provides call-based advertising technology and services. It focuses on driving performance based inbound sales calls to advertisers from online and mobile media. The firm’s partner network includes agencies, local advertising publishers, as well as affiliate and mobile networks. The company was founded by Carl Holmquist and Tobies Lindgren in 2008 and is headquartered in Uppsala, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
PrecisionBiotics Group Ltd.
 PrecisionBiotics Group Ltd. Pharmaceuticals: GenericHealth Technology PrecisionBiotics Group Ltd. operates as a healthcare company. It focuses on isolation, characterization, clinical evaluation, and formulation of unique bacterial strain and actives for inflammatory and infectious conditions. The company was founded by Barry Kiely in 1999 and is headquartered In Cork, Ireland. | Pharmaceuticals: Generic | Director/Board Member | |
| National University of Ireland | College/University | Doctorate Degree | |
| QHSLAB, INC. | Financial Conglomerates | Corporate Officer/Principal | |
Traplight Oy
 Traplight Oy Packaged SoftwareTechnology Services Traplight Oy develops mobile game communities where players can create and share their own games with their friends. It offers a user-generated content, goal oriented game play, and social gaming software. It produces the game What on Earth!, that tells the story of a curious extraterrestrial race who discover Voyager, a space probe launched into outer space. The company was founded by Riku-Pekka Rakkola, Jari Mikael Paananen, and Sami Antero Kalliokoski in 2010 and is headquartered in Tampere, Finland. | Packaged Software | Director/Board Member | |
| Medicines & Healthcare Products Regulatory Agency | General Government | Corporate Officer/Principal | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Akarna Therapeutics Ltd.
 Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member |
Statistieken
Internationaal
| Denemarken | 10 |
| Zweden | 9 |
| Verenigd Koninkrijk | 9 |
| Spanje | 8 |
| Verenigde Staten | 7 |
Sectoraal
| Health Technology | 21 |
| Finance | 8 |
| Consumer Services | 7 |
| Technology Services | 7 |
| Commercial Services | 4 |
Operationeel
| Director/Board Member | 272 |
| Chairman | 64 |
| Corporate Officer/Principal | 62 |
| Chief Executive Officer | 31 |
| Independent Dir/Board Member | 28 |
Sterkste connecties
- Beurs
- Insiders
- Andreas Segerros
- Bedrijfsconnecties
